ABBV adds $24B in market cap as Skyrizi and Rinvoq drive growth post-Humira, with more upside from a strong pipeline.

AbbVie rose to the challenge when its Humira patent expired, cementing its sterling reputation. Johnson & Johnson is a model of consistency and excellence among dividend stocks.

Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building a knockoff drug powerhouse and has become one of the world’s most successful female ...

Learn about cost, uses, and more for Uceris (budesonide), which is a prescription drug that treats ulcerative colitis in adults.